Translocating shRNA: a novel approach to RNA interference with Newcastle disease virus as viral vector
- PMID: 40643574
- PMCID: PMC12248247
- DOI: 10.1099/jgv.0.002127
Translocating shRNA: a novel approach to RNA interference with Newcastle disease virus as viral vector
Abstract
RNA interference is crucial in post-transcriptional gene silencing. Short hairpin RNA (shRNA) is particularly effective because it forms fully complementary matches with target mRNA, leading to its degradation. However, shRNA processing relies on nuclear microprocessors like Drosha, posing a challenge for RNA viral vectors that replicate exclusively in the cytoplasm. Although there have been reports of Drosha translocating to the cytoplasm upon viral infection, many RNA viruses, including Newcastle disease virus (NDV), remain inadequately studied in this context and, in some cases, fail to induce Drosha translocation for shRNA processing. In this study, we developed a novel approach to translocate an shRNA, expressed by NDV as an RNA viral vector, into the nucleus for Drosha processing. As a proof of concept, a recombinant NDV expressing the shRNA (rAF-shmcherry) with an AU-rich region at its 3' end in the expression cassette was constructed. This shRNA targets a constitutively expressed mCherry gene in a colorectal cancer cell line, SW620-mC. We confirmed the presence of the AU-rich shRNA in the nuclei of the rAF-shmcherry-infected SW620-mC using reverse transcription PCR (RT-PCR). The gene-silencing effect of the shRNA was then evaluated at mRNA and protein levels, showing ~90% downregulation of the mCherry transgene at 24 h post-infection and 70% downregulation of mCherry protein in SW620-mC at 48 h post-infection. This study marks the first exploration of NDV as an shRNA viral vector, presenting a promising approach for shRNA translocation that could be applicable to various RNA viruses.
Keywords: Drosha; Newcastle disease virus (NDV); ZC3H12D protein; short hairpin RNA; viral vector.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures


Similar articles
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Short-Term Memory Impairment.2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
NIH Consensus Statement on Management of Hepatitis C: 2002.NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. NIH Consens State Sci Statements. 2002. PMID: 14768714
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous